Copyright
©The Author(s) 2025.
World J Gastrointest Endosc. Feb 16, 2025; 17(2): 102532
Published online Feb 16, 2025. doi: 10.4253/wjge.v17.i2.102532
Published online Feb 16, 2025. doi: 10.4253/wjge.v17.i2.102532
Table 3 Outcomes of patients treated with medical management vs endoscopy, mean ± SD or n (%)
Variable | No endoscopy, n = 38 | Endoscopy, n = 38 | P value |
Mortality at 30 days | 8 (21.0) | 14 (36.8) | 0.13 |
Mortality at 1 year | 27 (71.1) | 28 (73.7) | 0.78 |
ICU admission | 12 (31.6) | 14 (36.8) | 0.63 |
PRBC transfusion | 31 (81.6) | 34 (89.5) | 0.47 |
PLT transfusion | 38 (100) | 37 (97.4) | 0.31 |
Recurrent bleeding | 13 (34.2) | 14 (36.8) | 0.68 |
Length of stay (day) | 18.2 ± 14.9 | 17.8 ± 25.7 | 0.94 |
- Citation: Alhumayyd B, Naumann A, Cashen A, Chen CH. Clinical impact of endoscopy in severely thrombocytopenic patients with hematologic malignancy experiencing gastrointestinal bleeding. World J Gastrointest Endosc 2025; 17(2): 102532
- URL: https://www.wjgnet.com/1948-5190/full/v17/i2/102532.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i2.102532